SCHEMBL525636

SCHEMBL525636

CCC1(OC(=O)C2CC3C=CC2C3)C2CC3CC(C2)CC1C3

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
ALDH1A1 P00352 8/20 0.37
POLB P06746 3/20 0.37
APEX1 P27695 1/20 0.37
RECQL P46063 1/20 0.37
BLM P54132 1/20 0.37
ESR2 Q92731 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
HPGD P15428 1/20 0.37
KMT2A Q03164 2/20 0.37
RAB9A P51151 1/20 0.36
MAPK1 P28482 1/20 0.34
EPHX2 P34913 2/20 0.33
ESR1 P03372 1/20 0.32
THRB P10828 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30209890 0.87 ALDH1A1 (0.44) KDM4ELMNAALDH1A1POLBAPEX1
SCHEMBL12251470 0.86 KDM4E (0.34) KDM4ELMNAALDH1A1POLBAPEX1
SCHEMBL721606 0.84 KDM4E (0.36) KDM4ELMNAALDH1A1POLBAPEX1
SCHEMBL23187878 0.83 KDM4E (0.41) KDM4ELMNAALDH1A1POLBAPEX1
SCHEMBL524854 0.83 KDM4E (0.41) KDM4ELMNAALDH1A1POLBAPEX1
SCHEMBL5025391 0.80 ALDH1A1 (0.41) KDM4ELMNAALDH1A1POLBAPEX1
SCHEMBL3870196 0.78 KDM4E (0.35) KDM4ELMNAALDH1A1POLBAPEX1
SCHEMBL7245314 0.76 POLB (0.32) POLB
SCHEMBL3434470 0.76 LMNA (0.41) KDM4ELMNAALDH1A1POLBAPEX1
SCHEMBL14560632 0.76 ALDH1A1 (0.45) KDM4ELMNAALDH1A1POLBAPEX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 371 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021146494-A1 FINE FRAGRANCE COMPOSITIONS CONTAINING NORBORNENE ESTER DERIVATIVES PROMERUS, LLC (US) 2021-07-22 WO claimed
US-11886119-B2 Material for forming underlayer film, resist underlayer film, method of producing resist underlayer film, and laminate MITSUI CHEMICALS, INC. (JP) 2024-01-30 US disclosed
CN-110709774-B Underlayer film forming material, resist underlayer film, method for producing resist underlayer film, and laminate 三井化学株式会社 2023-12-08 CN disclosed
US-20230185195-A1 MATERIAL FOR FORMING UNDERLAYER FILM, RESIST UNDERLAYER FILM, METHOD OF PRODUCING RESIST UNDERLAYER FILM, AND LAMINATE MITSUI CHEMICALS, INC. (JP) 2023-06-15 US disclosed
US-11599025-B2 Resin material for forming underlayer film, resist underlayer film, method of producing resist underlayer film, and laminate MITSUI CHEMICALS, INC. (JP) 2023-03-07 US disclosed
US-11556056-B2 Salt, acid generator, resist composition and method for producing resist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-01-17 US disclosed
US-11549080-B2 Fine fragrance compositions containing norbornene ester derivatives PROMERUS, LLC (US) 2023-01-10 US disclosed
US-20220177807-A1 FINE FRAGRANCE COMPOSITIONS CONTAINING NORBORNENE ESTER DERIVATIVES PROMERUS, LLC (US) 2022-06-09 US disclosed
WO-2021146494-A1 FINE FRAGRANCE COMPOSITIONS CONTAINING NORBORNENE ESTER DERIVATIVES PROMERUS, LLC (US) 2021-07-22 WO disclosed
CN-107207456-B Latent acids and their use 巴斯夫欧洲公司 2021-05-04 CN disclosed
US-20020006582-A1 Chemical amplification type positive resist compositions and sulfonium salts SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-01-17 US disclosed
US-20010046641-A1 Chemically amplified positive resist composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-11-29 US disclosed
US-20010044070-A1 Chemically amplified positive resist composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-11-22 US disclosed
EP-1154321-A1 Chemical amplification type positive resist compositions and sulfonium salts SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-11-14 EP disclosed
US-20010033987-A1 Chemically amplified positive resist composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-10-25 US disclosed
EP-1143299-A1 Chemically amplified positive resist composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-10-10 EP disclosed
EP-1128212-A2 Chemically amplified positive resist composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-08-29 EP disclosed
EP-1125917-A1 Alkyladamantyl esters and their preparation Chem Search Corporation (KR) 2001-08-22 EP disclosed
US-6222061-B1 FOR PREPARING FLAME RETARDANTS CHEM SEARCH CORP. (KR) 2001-04-24 US disclosed
EP-1041442-A1 Chemical amplification type positive resist SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2000-10-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11556056-B2 Salt, acid generator, resist composition and method for producing resist pattern CLIC1, OXSR1, RER1 KDM4E 2394/4885LMNA 3335/4885ALDH1A1 1211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.